Many previous studies showed that DNT cells producing IL-17 and IFN-γ expanded in patients with systemic lupus erythematosus (SLE) (Crispin et al., 2008) and were a potential biomarker for SLE (Alexander et al., 2020). The gene discussed is IFNG; the disease is systemic lupus erythematosus.